Tag: Sjögren’s syndrome

FcRn blocker nipocalimab improves disease activity in Sjögren’s disease

Presented By
Dr Ghaith Noaiseh, University of Kansas Medical Center, KS, USA
Trial
Phase 2, DAHLIAS
Conference
ACR 2024
Type
Peer-reviewed article

13 January 2025 11:15

Nipocalimab meets primary endpoint in Sjögren’s syndrome

Presented By
Prof. Jacques-Eric Gottenberg, Strasbourg University Hospital, France
Trial
Phase 2, DAHLIAS
Conference
EULAR 2024
Type
Peer-reviewed article

29 July 2024 14:38

Dazodalibep improves dryness, fatigue, and pain in patients with Sjögren’s syndrome with a high symptom burden

Presented By
Dr Chiara Baldini, University of Pisa, Italy
Trial
ALISS
Conference
EULAR 2023
Type
Peer-reviewed article

30 July 2023 23:25

Bruton’s tyrosine kinase inhibition: a novel treatment option for Sjögren’s syndrome?

Presented By
Prof. Thomas Dörner, Charité University Hospital, Germany
Trial
Phase 2, LOUiSSE
Conference
ACR 2022
Type
News article

1 December 2022 13:19

HS patients carry higher risk for systemic lupus erythematosus

Trial
phase 1
Conference
AAD 2020
Type
Peer-reviewed article

6 August 2020 13:04
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com